...
首页> 外文期刊>Stem cells and development >Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo.
【24h】

Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo.

机译:来源于人脂肪组织的间充质干细胞有利于体内肿瘤细胞的生长。

获取原文
获取原文并翻译 | 示例
           

摘要

Mesenchymal stem cells (MSCs) have generated a great deal of interest in clinical situations, due principally to their potential use in regenerative medicine and tissue engineering applications. However, the therapeutic application of MSCs remains limited, unless the favorable effects of MSCs for tumor growth in vivo and the long-term safety of the clinical applications of MSCs can be understood more thoroughly. In this study, MSCs derived from human adipose tissues (hASCs) together with tumor cells were transplanted subcutaneously or intracranially into BALB/c nude mice to observe tumor outgrowth. The results indicated that hASCs with H460 or U87MG cells promoted tumor growth in nude mice. Our histopathological analyses indicated that the co-injection of tumor cells with hASCs exerted no influence on the formation of intratumoral vessels. Co-culture of tumor cells with hASCs or the addition of conditioned medium (CM) from hASCs effected an increase in the proliferation of H460 or U87MG cells. Co-injection of hASCs with tumor cells effected an increase in tumor cell viability in vivo, and also induced a reduction in apoptotic cell death. CM from hASCs inhibited hydrogen peroxide-induced cell death in H460 or U87MG cells. These findings indicated that MSCs could favor tumor growth in vivo. Thus, it is necessary to conduct a study concerning the long-term safety of this technique before MSCs can be used as therapeutic tools in regenerative medicine and tissue engineering.
机译:间充质干细胞(MSCs)在临床上引起了极大的兴趣,这主要是由于它们在再生医学和组织工程应用中的潜在用途。但是,除非能更全面地理解MSC对体内肿瘤生长的有利作用以及MSC临床应用的长期安全性,否则MSC的治疗应用仍然受到限制。在这项研究中,将源自人类脂肪组织(hASCs)的MSC与肿瘤细胞一起皮下或颅内移植到BALB / c裸鼠中,观察肿瘤的生长。结果表明,具有H460或U87MG细胞的hASC促进了裸鼠的肿瘤生长。我们的组织病理学分析表明,肿瘤细胞与hASC的共同注射对肿瘤内血管的形成没有影响。将肿瘤细胞与hASCs共培养或从hASCs中加入条件培养基(CM),可增加H460或U87MG细胞的增殖。 hASC与肿瘤细胞的共同注射可提高体内肿瘤细胞的生存能力,并诱导凋亡细胞死亡的减少。 hASC中的CM抑制H460或U87MG细胞中过氧化氢诱导的细胞死亡。这些发现表明,MSC可能在体内促进肿瘤生长。因此,有必要进行关于该技术的长期安全性的研究,然后才能将MSC用作再生医学和组织工程中的治疗工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号